ELUVIA™

Drug-Eluting Vascular Stent System

Product Design

The Making of Eluvia
The Eluvia Stent is the first and only drug-eluting technology designed to sustain drug release beyond a year to deliver drug therapy when restenosis is most likely to occur.  Eluvia is based on a purpose-built stent platform designed to address the unique mechanical challenges of the SFA designed with the optimal amount of strength, flexibility and fracture resistance. In the MAJESTIC Trial Eluvia demonstrated the highest reported primary patency rates at 1 and 2 years amongst similar SFA trials.
Product Overview

Product Overview

Advanced drug-eluting technology for PAD.

Button
Clinical Programs

Clinical Programs

Unprecedented clinical data outcomes in the SFA.

Button
Sustained Drug Release

Sustained Drug Release

Delivers paclitaxel when restenosis is most likely.

Button
Top